We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
58 hedge funds and large institutions have $65.6M invested in Lineage Cell Therapeutics in 2013 Q2 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
36.82% more ownership
Funds ownership: 0% → 36.82% (+37%)
75% less call options, than puts
Call options by funds: $196K | Put options by funds: $775K
Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
58
Increased
–
Reduced
–
Closed
–
Calls
$196K
Puts
$775K
Net Calls
-$579K
Net Calls Change
-$579K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citadel Advisors
Miami,
Florida
| $2K | +$1.74K | +543 | New |
|
|
WA
52
WFG Advisors
Dallas,
Texas
| $2K | +$1.79K | +558 | New |
|
53
Citigroup
New York
| $2K | +$2.47K | +771 | New |
|
|
PSI
54
Pinnacle Summer Investments
Fairfax,
Virginia
| $1K | +$596 | +186 | New |
|
|
RFC
55
Russell Frank Company
Seattle,
Washington
| $1K | +$766 | +239 | New |
|
|
HF
56
Hoxton Financial
Shepherdstown,
West Virginia
| $1K | +$1.05K | +328 | New |
|
57
Creative Planning
Overland Park,
Kansas
| $1K | +$1.19K | +372 | New |
|
|
HNB
58
Huntington National Bank
Columbus,
Ohio
| – | +$794 | +248 | New |
|